Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 5/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.39 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9879639 | 0.86 | EPHX1 (0.50) | CASP2EPHX1 | |
| SCHEMBL23736376 | 0.84 | — | — | |
| SCHEMBL28879783 | 0.82 | — | — | |
| SCHEMBL11176825 | 0.81 | EPHX1 (0.52) | CASP2EPHX1 | |
| SCHEMBL22365675 | 0.81 | EPHX1 (0.52) | CASP2EPHX1 | |
| SCHEMBL14957807 | 0.81 | EPHX1 (0.52) | CASP2EPHX1 | |
| SCHEMBL18248636 | 0.81 | EPHX1 (0.52) | CASP2EPHX1 | |
| SCHEMBL11309804 | 0.81 | EPHX1 (0.52) | CASP2EPHX1 | |
| SCHEMBL11318989 | 0.81 | EPHX1 (0.52) | CASP2EPHX1 | |
| SCHEMBL10731551 | 0.81 | EPHX2 (0.49) | EPHX1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108675938-B | Novel method for preparing N-N-butylacrylamide | 常州大学 | 2019-12-31 | — | — | CN | claimed |
| US-11813596-B2 | Photocatalytic system and applications thereof | Max Planck Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-11-14 | — | — | US | disclosed |
| US-11813596-B2 | Photocatalytic system and applications thereof | Max Planck Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-11-14 | — | — | US | disclosed |
| US-11813596-B2 | Photocatalytic system and applications thereof | Max Planck Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-11-14 | — | — | US | disclosed |
| EP-3700910-B1 | PHOTOCATALYTIC SYSTEM AND APPLICATIONS THEREOF | MAX PLANCK GESELLSCHAFT (DE) | 2022-08-03 | — | — | EP | disclosed |
| EP-3700910-B1 | PHOTOCATALYTIC SYSTEM AND APPLICATIONS THEREOF | MAX PLANCK GESELLSCHAFT (DE) | 2022-08-03 | — | — | EP | disclosed |
| CN-106256175-B | Resin composition for permanent insulation film, multilayer printed wiring board, and method for producing same | 太阳油墨制造株式会社 | 2021-01-08 | — | — | CN | disclosed |
| US-20200290029-A1 | PHOTOCATALYTIC SYSTEM AND APPLICATIONS THEREOF | Max Planck Gesellschaft Zur Förderung Der Wissenschaften E.V (DE) | 2020-09-17 | — | — | US | disclosed |
| US-20200290029-A1 | PHOTOCATALYTIC SYSTEM AND APPLICATIONS THEREOF | Max Planck Gesellschaft Zur Förderung Der Wissenschaften E.V (DE) | 2020-09-17 | — | — | US | disclosed |
| EP-3700910-A1 | PHOTOCATALYTIC SYSTEM AND APPLICATIONS THEREOF | Max-Planck-Gesellschaft zur Förderung der Wissenschaften E. V. (DE) | 2020-09-02 | — | — | EP | disclosed |
| CN-108675938-B | Novel method for preparing N-N-butylacrylamide | 常州大学 | 2019-12-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200290029-A1 | PHOTOCATALYTIC SYSTEM AND APPLICATIONS THEREOF | HCCS, CRY1, PCBP1 | CASP2 2375/4885EPHX1 2184/4885MEN1 4166/4885 |
| US-11813596-B2 | Photocatalytic system and applications thereof | HCCS, CRY1, PCBP1 | CASP2 2375/4885EPHX1 2184/4885MEN1 4166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.